MarginsXMarginsX
Home › Markets › Health Care › CPIX

Cumberland Pharmaceuticals Inc. (CPIX)

CPIX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$5.21
-11.39% on the day
Market cap
$78.1M
Micro cap
Revenue · 2025
$44.5M
+17.6% on 2024
Net income · 2025
-$2.8M
-6.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1087294/000108729426000020/0001087294-26-000020-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCPIX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2009
SEC CIK0001087294
SEC industry codePharmaceutical Preparations
Incorporated inTN

Financials · 2025

LineValue
Revenue$44.5M
Net income-$2.8M
Operating income-$2.8M
Net margin-6.4%
Operating margin-6.3%
Revenue growth+17.6%
Cash$11.4M
Total assets$76.8M
P/E (computed)Net income was not positive
P/S (computed)1.8×

Warning signs

Cash runway
Cash-flow positive
$3.9M cash at June 30, 2026
Share count, 1 year
+0.3%
2025-11-05 to 2026-11-11 · +5.2% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$3.9M cash; operating cash flow $186K a quarter.Report 2026-06-30
Shares outstanding14,995,547 (2026-11-11); 14,956,627 a year earlier; 14,255,700 three years earlier.Cover page 2026-11-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCarr, Riggs & Ingram LLC, Nashville, Tennessee, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$166K-$4.3M$169K$3.9MNo debt tags$31.3M10-Q 2026-08-07
Q1 2026
2026-03-31
$9.1M-$3.3M$387K$11.0MNo debt tags$31.5M10-Q 2026-05-08
Q4 2025
2025-12-31
$13.7M-$1.4M$3K$11.4M$0$34.1M10-K 2026-03-09
Q3 2025
2025-09-30
$8.3M-$1.9M$187K$15.2MNo debt tags$30.8M10-K 2026-03-09
Q2 2025
2025-06-30
$381K-$741K$844K$16.1MNo debt tags$31.6M10-Q 2026-08-07
Q1 2025
2025-03-31
$11.7M$1.3M$3.9M$15.1MNo debt tags$41.1M10-Q 2026-05-08
Q4 2024
2024-12-31
$10.4M-$1.9M$1.9M$18.0M$5.1M$37.9M10-K 2026-03-09
Q3 2024
2024-09-30
$9.1M-$1.5M$476K$17.5MNo debt tags$36.8M10-K 2026-03-09

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-02-14
Latest annual report10-K2026-03-09
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K/A2026-11-16
Latest proxyDEFM14A2026-05-26

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+12.6%
1 month-18.0%
3 months-25.6%
Year to date+47.7%
1 year+181.3%
From 52-week high-34.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RANIRani Therapeutics Holdings Inc.$0.5403+2.66%$75.4M
KALAKALA BIO Inc.$3.83-8.02%$74.1M
TLSATiziana Life Sciences Ltd. Common Shares$0.5762+1.11%$73.3M
PLYXPolaryx Therapeutics Inc.$1.67-6.99%$83.2M
VTVTvTv Therapeutics Inc.$17.69-10.16%$71.0M
RLYBRallybio Corporation$15.43-1.88%$86.4M
COYACoya Therapeutics Inc.$3.00-4.15%$70.4M
NKTXNkarta Inc.$1.21+1.68%$86.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier